Latigo Biotherapeutics Inc.
NASDAQ:LTGOMedical - Pharmaceuticals
+$0.76 today
- Market cap
- $800.64M
- Beta
- 0.00
Volume 0.21M
Average 0.38M
LTGO Net Receivables
Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.
Net Receivables history
Currency unavailable · from the balance sheet
No Net Receivables data reported for this period type.
Net Receivables vs competitors
How LTGO compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $228.76M USD | +0.0% | +4.9% | 13.8% | |
| Mar 2026 | $125.64M USD | +19.9% | +8.0% | 10.4% | |
| Mar 2026 | $29.85M USD | +181.1% | -10.5% | 10.2% | |
LTGOLatigo Biotherapeutics Inc. | — | — | — | — | — |
| Peer median (excluding LTGO) | — | +19.9% | +4.9% | 10.4% | |
Competitors are the stored peer set for LTGO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Latigo Biotherapeutics Inc.
NASDAQ:LTGO
Intrinsic Alpha fair value
Locked
Current Price
$13.31
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.